Please use this identifier to cite or link to this item:
http://repo.tma.uz/xmlui/handle/1/1015
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2025-03-06T03:43:07Z | - |
dc.date.available | 2025-03-06T03:43:07Z | - |
dc.date.issued | 2024-03-16 | - |
dc.identifier.issn | 2749-3644 | - |
dc.identifier.uri | http://repo.tma.uz/xmlui/handle/1/1015 | - |
dc.description.abstract | Hepatotoxicity is damage caused by exposure to a drug or non- pharmacological agents. Risk factors include: individual intolerance, age, gender, alcohol consumption, smoking, concomitant use of other drugs, liver disease, genetic and environmental factors. [1–3] Although most lipophilic drugs can cause hepatotoxicity , [4] antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), and anticonvulsants are the pharmacological groups that are the most common causes. [1, 5-9]. Among the drugs administered intravenously, antibiotics and neoplasia drugs are mostly associated with liver toxicity | en_US |
dc.language.iso | en | en_US |
dc.publisher | World Bulletin of Public Health (WBPH) | en_US |
dc.relation.ispartofseries | volume-32; | - |
dc.subject | Hepatotoxicity, intolerance, age, gender, alcohol consumption, smoking, concomitant use of other drugs, liver disease, genetic and environmental factors. | en_US |
dc.title | NEW APPROACHES IN THE TREATMENT OF METABOLIC DISORDERS IN LIVER FAILURE | en_US |
dc.type | Article | en_US |
Appears in Collections: | Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
NEW APPROACHES IN THE TREATMENT OF METABOLIC DISORDERS IN LIVER FAILURE.pdf | 223.24 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.